Relay Therapeutics Earnings
NASDAQ: RLAYHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.40
Relay Therapeutics earnings summary
Relay Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.40. In its most recent report on Aug 6, 2026 (Q2 2026), RLAY posted EPS of $-0.41. Revenue for the quarter was $350,000.
Across the last 16 reports, RLAY shares moved an average of 4.6% (in either direction) in the first trading session after results, rising 7 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
RLAY earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.41 | — | +0.5% |
| May 5, 2026 | — | $-0.41 | — | -4.4% |
| Feb 26, 2026 | — | $-0.31 | — | -3.6% |
| Nov 6, 2025 | — | $-0.43 | — | +4.0% |
| Aug 7, 2025 | — | $-0.41 | — | +9.9% |
| May 5, 2025 | — | $-0.46 | — | -6.3% |
| Feb 26, 2025 | — | $-0.42 | — | +1.5% |
| Nov 6, 2024 | — | $-0.63 | — | -17.7% |
| Aug 6, 2024 | — | $-0.69 | — | -3.7% |
| May 2, 2024 | — | $-0.62 | — | -8.8% |
| Feb 22, 2024 | — | $-0.66 | — | +0.8% |
| Nov 2, 2023 | — | $-0.54 | — | +1.9% |
| Aug 8, 2023 | — | $-0.81 | — | -1.3% |
| May 4, 2023 | — | $-0.78 | — | -9.1% |
| Feb 23, 2023 | — | $-0.55 | — | +0.4% |
| Nov 3, 2022 | — | $-0.76 | — | 0.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.